These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
318 related articles for article (PubMed ID: 8558525)
41. Comparison of [123I]beta-CIT and [123I]IPCIT as single-photon emission tomography radiotracers for the dopamine transporter in nonhuman primates. Scanley BE; al-Tikriti MS; Gandelman MS; Laruelle M; Zea-Ponce Y; Baldwin RM; Zoghbi SS; Hoffer PB; Charney DS; Wang S Eur J Nucl Med; 1995 Jan; 22(1):4-11. PubMed ID: 7698153 [TBL] [Abstract][Full Text] [Related]
42. Visualization of ischemic insult in caudate putamen with beta-CIT. Fujita M; Shimada S; Tohyama M; Nishimura T J Nucl Med; 1996 Jul; 37(7):1214-8. PubMed ID: 8965201 [TBL] [Abstract][Full Text] [Related]
43. Synthesis, radiosynthesis, and biological evaluation of carbon-11 and iodine-123 labeled 2beta-carbomethoxy-3beta-[4'-((Z)-2-haloethenyl)phenyl]tropanes: candidate radioligands for in vivo imaging of the serotonin transporter. Plisson C; McConathy J; Martarello L; Malveaux EJ; Camp VM; Williams L; Votaw JR; Goodman MM J Med Chem; 2004 Feb; 47(5):1122-35. PubMed ID: 14971892 [TBL] [Abstract][Full Text] [Related]
44. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter. Dutta AK; Xu C; Reith ME J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474 [TBL] [Abstract][Full Text] [Related]
45. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes. Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303 [TBL] [Abstract][Full Text] [Related]
46. [O-methyl-11C]beta-CIT-FP, a potential radioligand for quantitation of the dopamine transporter: preparation, autoradiography, metabolite studies, and positron emission tomography examinations. Lundkvist C; Halldin C; Swahn CG; Hall H; Karlsson P; Nakashima Y; Wang S; Milius RA; Neumeyer JL; Farde L Nucl Med Biol; 1995 Oct; 22(7):905-13. PubMed ID: 8547888 [TBL] [Abstract][Full Text] [Related]
47. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters. Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762 [TBL] [Abstract][Full Text] [Related]
48. Synthesis, structure, dopamine transporter affinity, and dopamine uptake inhibition of 6-alkyl-3-benzyl-2-[(methoxycarbonyl)methyl]tropane derivatives. Lomenzo SA; Izenwasser S; Katz JL; Terry PD; Zhu N; Klein CL; Trudell ML J Med Chem; 1997 Dec; 40(26):4406-14. PubMed ID: 9435910 [TBL] [Abstract][Full Text] [Related]
49. Binding of cocaine-like radioligands to the dopamine transporter at 37 degrees C: effect of Na+ and substrates. Wang LC; Cui XN; Chen N; Reith ME J Neurosci Methods; 2003 Dec; 131(1-2):27-33. PubMed ID: 14659820 [TBL] [Abstract][Full Text] [Related]
50. N-(3-lodoprop-2E-enyl)-2beta-carbomethoxy-3beta-(3',4'-dichloro phenyl)nortropane (beta-CDIT), a tropane derivative: pharmacological characterization as a specific ligand for the dopamine transporter in the rodent brain. Garreau L; Emond P; Belzung C; Guilloteau D; Frangin Y; Besnard JC; Chalon S J Pharmacol Exp Ther; 1997 Jul; 282(1):467-74. PubMed ID: 9223589 [TBL] [Abstract][Full Text] [Related]
51. Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson's disease. Andringa G; Drukarch B; Bol JG; de Bruin K; Sorman K; Habraken JB; Booij J Neuroimage; 2005 Jul; 26(4):1150-8. PubMed ID: 15908232 [TBL] [Abstract][Full Text] [Related]
52. Novel N-substituted 3 alpha-[bis(4'-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter. Agoston GE; Wu JH; Izenwasser S; George C; Katz J; Kline RH; Newman AH J Med Chem; 1997 Dec; 40(26):4329-39. PubMed ID: 9435902 [TBL] [Abstract][Full Text] [Related]
53. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666 [TBL] [Abstract][Full Text] [Related]
54. Synthesis of 2 beta-acyl-3 beta-aryl-8-azabicyclo[3.2.1]octanes and their binding affinities at dopamine and serotonin transport sites in rat striatum and frontal cortex. Davies HM; Saikali E; Huby NJ; Gilliatt VJ; Matasi JJ; Sexton T; Childers SR J Med Chem; 1994 Apr; 37(9):1262-8. PubMed ID: 8176704 [TBL] [Abstract][Full Text] [Related]
55. SPECT measurement of iodine-123-beta-CIT binding to dopamine and serotonin transporters in Parkinson's disease: correlation with symptom severity. Kim SE; Lee WY; Choe YS; Kim JH Neurol Res; 1999 Apr; 21(3):255-61. PubMed ID: 10319333 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and monoamine transporter binding properties of 3beta-(3',4'-disubstituted phenyl)tropane-2beta-carboxylic acid methyl esters. Carroll FI; Blough BE; Nie Z; Kuhar MJ; Howell LL; Navarro HA J Med Chem; 2005 Apr; 48(8):2767-71. PubMed ID: 15828814 [TBL] [Abstract][Full Text] [Related]
57. 2-Carbomethoxy-3-(diarylmethoxy)-1 alpha H, 5 alpha H-tropane analogs: synthesis and inhibition of binding at the dopamine transporter and comparison with piperazines of the GBR series. Meltzer PC; Liang AY; Madras BK J Med Chem; 1996 Jan; 39(2):371-9. PubMed ID: 8558504 [TBL] [Abstract][Full Text] [Related]
58. Synthesis, ligand binding, and quantitative structure-activity relationship study of 3 beta-(4'-substituted phenyl)-2 beta-heterocyclic tropanes: evidence for an electrostatic interaction at the 2 beta-position. Kotian P; Mascarella SW; Abraham P; Lewin AH; Boja JW; Kuhar MJ; Carroll FI J Med Chem; 1996 Jul; 39(14):2753-63. PubMed ID: 8709106 [TBL] [Abstract][Full Text] [Related]